Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Thoracic 3

Conditions

Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 51Carboplatin 51pembrolizumab 46Magnetic Resonance Spectroscopy 43Pemetrexed 40Cisplatin 35durvalumab 24Paclitaxel 24osimertinib 20Nivolumab 19Gemcitabine 19Radiosurgery 17Docetaxel 17atezolizumab 14Taxes 12Radiotherapy 12Immunoglobulin G 12Disulfides 12130-nm albumin-bound paclitaxel 12Radiation 11Etoposide 11Educational Status 11Biopsy 11Drug Therapy 10Blood Specimen Collection 10Platinum 9Early Intervention, Educational 9Cetuximab 9Methods 8Bevacizumab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Lung Neoplasms × Thoracic Surgery, Video-Assisted × 90 days × Clear all
NCT04067830 2026-05-18

Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer

Roswell Park Cancer Institute

Phase 2 Recruiting
220 enrolled
Thoracic

Lung Neoplasms

NCT06038227 2026-04-06

LARCS

Intuitive Surgical

Recruiting
512 enrolled
Thoracic

Lung Neoplasms

NCT06943664 2026-03-24

Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer

Roswell Park Cancer Institute

Phase 2 Not yet recruiting
27 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡